Rogier Sanders' research centres on HIV and the development of vaccines for infectious diseases. Working with fellow researchers at the AMC-UvA and New York's Cornell University, he successfully created an artificial variant of the protein responsible for HIV antibodies.

As a lecturer, Sanders will concentrate on the field of experimental vaccines for viruses such as HIV, hepatitis C and influenza. He will be teaching mainly at the AMC Graduate School and Amsterdam University College (AUC).

As a virologist, Sanders holds posts at both the AMC-UvA and Cornell's Weill Medical College. He is also the principal investigator for research into vaccine design at the AMC-UvA. Sanders is the recipient of a Starting Investigator Grant from the European Research Council (ERC) and numerous other research grants and fellowship awards.